299 related articles for article (PubMed ID: 11752067)
21. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Schröder O; Hör G; Hertel A; Baum RP
Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
[TBL] [Abstract][Full Text] [Related]
22. Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
Kofoed KF; Carstensen S; Hove JD; Freiberg J; Bangsgaard R; Holm S; Rabøl A; Hesse B; Arendrup H; Kelbaek H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):991-8. PubMed ID: 12173011
[TBL] [Abstract][Full Text] [Related]
23. Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; de Boer J; Jager PL
J Nucl Cardiol; 2006; 13(2):210-9. PubMed ID: 16580957
[TBL] [Abstract][Full Text] [Related]
24. Delayed enhancement of myocardial FDG uptake on glucose loading FDG-PET in NIDDM patient.
Tsuchida T; Yonekura Y; Wada Y; Sadato N; Yamamoto K; Waki A; Nakano A; Lee JD; Hayashi N; Ishii Y
Ann Nucl Med; 1997 Nov; 11(4):331-4. PubMed ID: 9460526
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
[TBL] [Abstract][Full Text] [Related]
26. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
Fallavollita JA; Luisi AJ; Yun E; deKemp RA; Canty JM
J Nucl Cardiol; 2010 Aug; 17(4):637-45. PubMed ID: 20387134
[TBL] [Abstract][Full Text] [Related]
27. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
[TBL] [Abstract][Full Text] [Related]
28. Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
Fath-Ordoubadi F; Pagano D; Marinho NV; Keogh BE; Bonser RS; Camici PG
Am J Cardiol; 1998 Jul; 82(1):26-31. PubMed ID: 9671004
[TBL] [Abstract][Full Text] [Related]
29. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Schaefer WM; Lipke CS; Nowak B; Kaiser HJ; Reinartz P; Buecker A; Krombach GA; Buell U; Kühl HP
J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
[TBL] [Abstract][Full Text] [Related]
31. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
[TBL] [Abstract][Full Text] [Related]
33. Effect of nicotinic acid on exogenous myocardial glucose utilization.
Stone CK; Holden JE; Stanley W; Perlman SB
J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
[TBL] [Abstract][Full Text] [Related]
34. Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.
Søndergaard HM; Bøttcher M; Marie Madsen M; Schmitz O; Hansen SB; Nielsen TT; Bøtker HE
J Clin Endocrinol Metab; 2006 Dec; 91(12):4854-61. PubMed ID: 16984986
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Brogsitter C; Grüning T; Weise R; Wielepp P; Lindner O; Körfer R; Burchert W
J Nucl Med; 2005 Jan; 46(1):19-24. PubMed ID: 15632028
[TBL] [Abstract][Full Text] [Related]
36. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
[TBL] [Abstract][Full Text] [Related]
37. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
38. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
[TBL] [Abstract][Full Text] [Related]
39. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
40. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]